New use for cannabinoid

Details for Australian Patent Application No. 2005305675 (hide)

Owner GW Pharma Limited

Inventors Guy, Geoffrey; Pertwee, Roger

Agent Davies Collison Cave

Pub. Number AU-A-2005305675

PCT Pub. Number WO2006/054057

Priority 0425248.2 16.11.04 GB; 0515704.5 29.07.05 GB

Filing date 15 November 2005

Wipo publication date 26 May 2006

International Classifications

A61K 31/00 (2006.01)

A61K 31/33 (2006.01) - Heterocyclic compounds

A61K 31/454 (2006.01)

A61K 36/185 (2006.01) Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines - Magnoliopsida (dicotyledons)

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

24 May 2007 PCT application entered the National Phase

  PCT publication WO2006/054057 Priority application(s): WO2006/054057

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005305677-Neutralising antibody molecules having specificity for human IL-17

2005305672-Systems and methods for determining the location of a pig in a pipeline